Gentiva Health Services Misses on the Top and Bottom Lines
Gentiva Health Services (NAS: GTIV) reported earnings on Feb. 7. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Gentiva Health Services missed estimates on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP earnings per share increased significantly.
Gross margins dropped, operating margins increased, net margins grew.
Gentiva Health Services tallied revenue of $425.0 million. The eight analysts polled by S&P Capital IQ looked for a top line of $433.7 million on the same basis. GAAP reported sales were 5.4% lower than the prior-year quarter's $449.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.31. The seven earnings estimates compiled by S&P Capital IQ predicted $0.34 per share. GAAP EPS of $0.28 for Q4 were 100% higher than the prior-year quarter's $0.14 per share. (The prior-year quarter included $0.04 per share in earnings from discontinued operations.)
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 46.1%, 30 basis points worse than the prior-year quarter. Operating margin was 9.1%, 30 basis points better than the prior-year quarter. Net margin was 2.0%, 100 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $438.2 million. On the bottom line, the average EPS estimate is $0.29.
Next year's average estimate for revenue is $1.74 billion. The average EPS estimate is $1.28.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 270 members out of 285 rating the stock outperform, and 15 members rating it underperform. Among 86 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 82 give Gentiva Health Services a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentiva Health Services is hold, with an average price target of $13.20.
Is Gentiva Health Services the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Gentiva Health Services to My Watchlist.
The article Gentiva Health Services Misses on the Top and Bottom Lines originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.